These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38141900)

  • 1. Cardioneuroablation for vasovagal syncope: Sober second thoughts.
    Sheldon RS; Raj SR
    Heart Rhythm; 2024 Mar; 21(3):292-293. PubMed ID: 38141900
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope.
    Tu B; Wu L; Hu F; Fan S; Liu S; Liu L; Ding L; Zheng L; Yao Y
    Heart Rhythm; 2022 Apr; 19(4):562-569. PubMed ID: 34896621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioneuroablation: A game-changer for vasovagal syncope.
    Almeida S
    Rev Port Cardiol; 2023 Oct; 42(10):831-833. PubMed ID: 37263497
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardioneuroablation for the effective treatment of recurrent vasovagal syncope to restore driving abilities.
    Reichert A; Wileczek A; Stec S
    Kardiol Pol; 2022; 80(11):1158-1160. PubMed ID: 35946179
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardioneuroablation for recurrent vasovagal syncope: Important questions need to be answered.
    Wieling W; Jardine DL
    Heart Rhythm; 2021 Dec; 18(12):2167-2168. PubMed ID: 34481983
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.
    Francia P; Viveros D; Falasconi G; Penela D; Soto-Iglesias D; Martí-Almor J; Alderete J; Saglietto A; Bellido AF; Franco-Ocaña P; Zaraket F; Matiello M; Fernández-Armenta J; San Antonio R; Berruezo A
    Heart Rhythm; 2023 Sep; 20(9):1279-1286. PubMed ID: 37329936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioneuroablation for the treatment of vagally mediated atrial fibrillation and vasovagal syncope.
    Wróblewska A; Wileczek A; Reichert A; Stec S
    Kardiol Pol; 2021; 79(10):1151-1152. PubMed ID: 34292561
    [No Abstract]   [Full Text] [Related]  

  • 8. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results.
    Pachon JC; Pachon EI; Cunha Pachon MZ; Lobo TJ; Pachon JC; Santillana TG
    Europace; 2011 Sep; 13(9):1231-42. PubMed ID: 21712276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioneuroablation: Present status as a tenable therapy for vasovagal syncope.
    Sutton R; Lim PB
    Turk Kardiyol Dern Ars; 2019 Jan; 47(1):1-3. PubMed ID: 30628895
    [No Abstract]   [Full Text] [Related]  

  • 10. [The tilt-table test: is it essential for adequate treatment of vasovagal syncope? Arguments in favor].
    Moya i Mitjans A; Permanyer-Miralda G; Sagristà Sauleda J; Rius Gelabert T
    Rev Esp Cardiol; 1997 Jun; 50(6):368-73. PubMed ID: 9304159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey.
    Vandenberk B; Morillo CA; Sheldon RS; Chew DS; Aksu T; Raj SR
    Heart Rhythm; 2021 Dec; 18(12):2160-2166. PubMed ID: 34419666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation.
    Aksu T; Guler TE; Bozyel S; Yalin K; Gopinathannair R
    Europace; 2020 Sep; 22(9):1320-1327. PubMed ID: 32898255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tilt testing for syncope.
    Spearritt D; Pascoe H; Patrick J
    Aust Crit Care; 2000 Nov; 13(4):159-62. PubMed ID: 16948208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocardiogenic syncope: Pacemaker or cardioneuroablation?
    Pachon-M JC
    Heart Rhythm; 2020 May; 17(5 Pt A):829-830. PubMed ID: 32113895
    [No Abstract]   [Full Text] [Related]  

  • 15. [The tilt-table test: is it essential for adequate treatment of vasovagal syncope? Arguments against].
    Ruiz Granell R; García Civera R; Morell Cabedo S; Botella Solana S; López Merino V
    Rev Esp Cardiol; 1997 Jun; 50(6):374-82. PubMed ID: 9304160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of nitrate-stimulated tilt testing in patients with suspected vasovagal syncope and a healthy control group.
    Aerts AJ; Dendale P; Block P; Dassen WR
    Am Heart J; 2005 Aug; 150(2):251-6. PubMed ID: 16086926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope.
    Brignole M; Aksu T; Calò L; Debruyne P; Deharo JC; Fanciulli A; Fedorowski A; Kulakowski P; Morillo C; Moya A; Olshansky B; Piotrowski R; Stec S; Wichterle D
    Europace; 2023 May; 25(5):. PubMed ID: 37021351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-upright tilt table testing for children with vasovagal syncope.
    Haq NU; Heydarian M
    W V Med J; 1997; 93(1):371-3. PubMed ID: 9123941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-up tilt test for recurrent syncope in pilots.
    Carter D; Pokroy R; Grossman A; Azaria B; Goldstein L
    Aviat Space Environ Med; 2005 Dec; 76(12):1167-9. PubMed ID: 16370268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pain-provoked versus standard 40-min tilt table test for the conformation of vasovagal syncope.
    Adamec I; Junaković A; Krbot Skorić M; Habek M
    Neurol Sci; 2022 Aug; 43(8):4847-4851. PubMed ID: 35449384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.